Archives: 2025-03-08

FDA Approves Tenecteplase for Acute Ischemic Stroke

Key Takeaways The FDA has approved tenecteplase (TNKase; Genentech) for the treatment of acute ischemic stroke (AIS) in adults, according to a Genentech announcement.1 The thrombolytic medicine is an intravenous (IV) tissue plasminogen activator that is clot-dissolving, administered as a single 5-second IV bolus. The company noted that it will be providing a 25-mg vial configuration

Read More


Cultured tissue from nasal cartilage cells helps with complicated knee injuries

Damage to joint cartilage is painful and limits mobility. Researchers at the University of Basel and the University Hospital of Basel are therefore developing cartilage implants from cells from the nasal septum. A recent study shows that a longer maturation time for the cultured cartilage brings a significant improvement even in cases of complicated cartilage

Read More


Feeling is believing: Bionic hand ‘knows’ what it’s touching and grasps like a human

Pioneering prosthetic hand carefully conforms and adjusts its grasp to avoid damaging or mishandling whatever it holds Key Takeaways Johns Hopkins University engineers have developed a pioneering prosthetic hand that can grip plush toys, water bottles, and other everyday objects like a human, carefully conforming and adjusting its grasp to avoid damaging or mishandling whatever

Read More


Physical Activity may help delay cognitive decline by modulating neurodegeneration and AD-specific tau pathologies: a study reveals

Alzheimer disease (AD), the most common cause of cognitive impairment, is characterized by β-amyloid (Aβ) plaques and tau neurofibrillary tangles, which lead to neuroinflammation, neurodegeneration, and cognitive decline. Among various interventions, physical activity (PA) is widely recommended. Numerous studies suggest that PA not only slows cognitive decline but also improves specific cognitive functions. Potential mechanisms underlying the protective

Read More